Login/Register
  • 中文
  • English

News

Pharmosa Biopharm Announces EU Orphan Drug Designation for Investigational Drug L608

Pharmosa Biopharm announced on June 24 that it has received official written notification from the European Commission, confirming that its investigational drug L608 has been granted Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for the treatment of systemic scleroderma (SSc).

Read more
Jun 24, 2025
Onyx Healthcare Builds Third Growth Engine, High-Margin Projects to Continue Shipping in H2 with Positive Outlook for the Year
Jun 24, 2025
Heron Neutron Medical Aims to Go Public by Year-End, Pushing Taiwan-Made BNCT onto the Global Stage
Jun 24, 2025
UNICOCELL BIOMED Submits Listing Application, Eyes Board Transition in Q4
Jun 24, 2025
Merry Life’s Alzheimer’s Drug TML-6 Receives FDA Approval for Global Phase II Clinical Trial
Jun 23, 2025
Genomics BioSci & Tech. Targets Profitability and Launches IPO Plan for 2025
Jun 23, 2025
TaiMed Biologics Announces Phase IIb Clinical Trial of TMB-365/380, Marking a Major Milestone in Transforming HIV Treatment
Jun 23, 2025
CHC Healthcare Group Targets Profit Growth with Three Strategic Initiatives
Jun 23, 2025
EU MDR Fully Enforced by 2028: Sixteen Taiwanese Companies, Including Qisda and United Orthopedic, Secure Early Market Access
Jun 20, 2025
Lotus Pharmaceutical to Acquire Five Drug Licenses in Vietnam for NT$457 Million, Accelerating ASEAN Expansion

Most Watched

Recommended

High Concentration Lutein & American Ginseng Capsules
Simpson Biotech Co., Ltd.
ASUS EndoAim AI Endoscopy System
ASUSTek Computer Inc.
Mitochondrial Transplantation Ameliorates Oxidative Stress and Inflammation in Rheumatoid Arthritis and Osteoarthritis Rat Models
E-Da Health Care Group

Industry Watch

Read more